Financial calendar

October 27 2021
Trading and redemption of warrants

Last day of trading 

October 29 2021
Last day for redemption of warrants
February 25 2022
End of year report
March 25 2022
Annual Report
April 25 2022
Annual General Meeting
May 27 2022
Interim report Q2 2022
August 30 2022
Interim report Q2 2022
November 18 2022
Interim report Q3 2022

We are a Swedish medical technology company listed on NGM Nordic SME.

Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.

We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.

Please note that the MAR rules (Market Abuse Regulation) prohibits us from providing information to individual inquirers regarding matters of the company's share, share price, economy and financials, commercial and scientific activities, and other information that potentially can alter the Market valuation of the traded share. We refer in general to the public information published by the company for such questions. Hence, emails with such questions will not be responded to individually.

IR contact